SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 141 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.88 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $226 | -7.8% | 9,770 | +4.7% | 0.00% | -50.0% |
| Q2 2023 | $245 | -9.9% | 9,329 | -11.7% | 0.00% | 0.0% |
| Q1 2023 | $272 | +27.7% | 10,569 | +29.1% | 0.00% | 0.0% |
| Q4 2022 | $213 | -99.9% | 8,184 | -8.0% | 0.00% | 0.0% |
| Q3 2022 | $254,000 | +10.0% | 8,897 | +117.1% | 0.00% | +100.0% |
| Q1 2022 | $231,000 | -1.7% | 4,099 | +8.1% | 0.00% | 0.0% |
| Q4 2021 | $235,000 | +17.5% | 3,792 | +20.1% | 0.00% | 0.0% |
| Q3 2021 | $200,000 | -3.4% | 3,157 | +25.8% | 0.00% | 0.0% |
| Q2 2021 | $207,000 | – | 2,510 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 5,831,307 | $480,558,000 | 31.49% |
| Consonance Capital Management LP | 1,199,339 | $98,838,000 | 11.90% |
| Boxer Capital, LLC | 2,075,905 | $171,075,000 | 6.04% |
| Perceptive Advisors | 9,699,824 | $799,362,000 | 5.19% |
| Orbimed Advisors | 6,044,266 | $498,108,000 | 5.04% |
| Samsara BioCapital, LLC | 169,852 | $13,998,000 | 1.73% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1,375,775 | $113,378,000 | 1.50% |
| SPHERA FUNDS MANAGEMENT LTD. | 195,117 | $16,080,000 | 1.09% |
| Artal Group S.A. | 500,000 | $41,205,000 | 0.84% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 558,574 | $46,032,000 | 0.82% |